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Abstract – The function of pancreatic β-cells is to produce and secrete insulin, a crucial hormone in carbohydrate metabo-
lism. The transcription factor PDX1 is required for insulin gene transcription and mature β-cell function. Since this factor 
is regulated by triiodothyronine, a disturbance in insulin biosynthesis and/or secretion is usually related to a deficiency 
of this hormone. In the present study, we used methods of immunohistochemistry, stereology and electron microscopy 
to explore the correlation between altered thyroid status and insulin synthesis/secretion in a model of methimazole-in-
duced hypothyroidism in rats. In hypothyroid animals fewer functional PDX1-positive β-cells were detected in the islets 
of Langerhans, while insulin immunostaining was stronger. Stereological analysis of β-cell granules revealed more numer-
ous immature insulin granules in hypothyroid rats. Taken together, these data suggest that the applied treatment caused 
impaired insulin synthesis and secretion. Rare cells with granules characteristic for both α- and β-cells observed in hypo-
thyroid animals could provide functional compensation for diminished insulin synthesis.
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INTRODUCTION
The pancreas is a gland with both endocrine and 
exocrine functions. Its endocrine function is based 
on the secretory action of several types of endocrine 
cells that cluster together to form the islets of Lang-
erhans. The most numerous of these cells are β-cells 
that are responsible for insulin synthesis and secre-
tion. Insulin has a key regulatory role in carbohydrate 
and lipid metabolism, in particular their storage and 
utilization (Saltiel and Kahn, 2001).
The primary stimulus for insulin secretion, but 
also for insulin gene transcription and insulin mRNA 
translation, is an increase in the blood glucose level 
(Permutt and Kipnis, 1972; Goodison et al., 1992). 
After insulin is synthesized on the rough endoplas-
mic reticulum and processed in the Golgi complex, it 
is packed in secretory granules, where further modi-
fication and final storage take place. At the molecular 
level, insulin gene expression is stimulated by tran-
scription  factors  PDX1  (pancreatic  and  duodenal 
homeobox-1)  and  NeuroD1  (neurogenic  differen-
tiation 1), which are both necessary for maintaining 
mature β-cell function (Andrali et al., 2008; Kaneto 
et al., 2009). Many hormones, with thyroid hormone 
triiodothyronine (T3) among them, are involved in 
the  positive  regulation  of  these  transcription  fac-
tors (Campbell and Macfarlane, 2002; Lin and Sun, 
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In mammals, an altered thyroid status adversely 
affects many organs and tissues, including the pan-
creas (Lu et al., 1988; Lee et al., 1989). So far, pub-
lished data considering the concentration of insulin 
in the blood in a common thyroid disorder such as 
hypothyroidism  are  surprisingly  inconsistent  and 
often  contradictory.  However,  probably  the  most 
numerous are reports describing decreased insulin 
levels  due  to  the  negative  regulation  of  its  secre-
tion from β-cells in the systemic hypothyroid state, 
(Katsilambros et al., 1972; Lenzen and Bailey, 1984; 
Gomez Dumm et al., 1985; Cortizo et al., 1985; Ra-
mos et al., 1998, 2001). 
Given this background, the aim of the present 
study  was  to  illustrate  and  quantitatively  demon-
strate the correlation of insulin synthesis/secretion 
with thyroid hormone concentration in the milieu of 
their systemic deprivation, employing immunohis-
tochemistry, electron microscopy and stereological 
methods.
MATERIALS AND METHODS
Animals and treatment
Male Wistar rats (Rattus norvegicus) 8 weeks in age 
and weighing 210 ± 35 g, were acclimated to 21±1ºC 
and maintained under an intermittent 12 h periods 
of light and dark. Five days before the beginning of 
the experiment, the rats were individually housed 
into cages. They were divided into two groups, each 
consisting of 8 animals. The first group was the intact 
control and was given commercial rat food and wa-
ter ad libitum. The rats from the second group had 
free access to both commercial rat food and a 0.02% 
(w/v)  methimazole  (2-mercapto-1-methyl-imida-
zole, MMI) (Sigma-Aldrich, St. Louis, MO) solution 
in tap water. Food and fluid input were monitored 
during the experiment, for three weeks.
At  the  end  of  the  experiment,  the  rats  were 
weighed and decapitated using a guillotine (Harvard 
Apparatus, Holliston, MA). The pancreas was quickly 
excised, freed of fat tissue on ice and weighed. Rela-
tive pancreatic mass was expressed as a percentage of 
the body mass (BM). Blood was collected from the 
trunk after decapitation. Animal handling and treat-
ment were carried out in accordance with the Serbian 
Laboratory Animal Protection Law proposed guide-
lines and protocols, approved by the Ethical Com-
mittee of Faculty of Biology, University of Belgrade.    
Insulin,  total  triiodothyronine  (T3)  and  total 
thyroxin (T4) serum levels were measured by the 
RIA method (INEP, Zemun, Serbia).
Light microscopy
Pancreases were fixed in 10% (v/v) neutral buffered 
formalin. After fixation, each pancreas was cut into 
eight uniform pieces. Four pieces were selected in a 
systematic random manner (Gundersen and Jensen, 
1987). The samples taken from each animal were de-
hydrated in an ascending concentration of alcohol, 
cleared in xylol and embedded in paraplast. From 
each block of pancreas, 5 µm thick sections were ob-
tained, using a Reichert rotation microtome.
For identifying the presence of dead cells, sec-
tions were incubated in 1 mg/ml propidium iodide 
solution in water for 10 min. Propidium iodide binds 
to the nuclei in all cells because we are dealing with 
fixed tissue. However, apoptotic cells have condensed 
nuclei, as opposed to heterochromatin staining in 
living cells at the moment of fixation. Sections were 
observed on a fluorescence microscope Zeiss Ob-
server.Z1 and images taken using the AxioCamMR3 
and AxioVision Rel4.7 software.
Immunohistochemistry
For identification of β-cells, immunohistochemistry 
was performed using the labeled streptavidin biotin 
(LSAB) method. The sections were incubated with 
antiserum  against  insulin  (polyclonal  guinea  pig 
anti-insulin A0564, Dako, 1:500). Incubation with a 
primary antibody was performed at room tempera-
ture for 60 min. 
To demonstrate cells in active phases of the cell 
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used (M7248, DakoCytomation, 1:30). Before 30 min 
incubation with primary antibody at room tempera-
ture, heat-induced epitope retrieval was performed 
(20 min. in 10mM citrate buffer pH 6).
Immunostaining with primary anti-PDX1 anti-
body (rabbit polyclonal ab47267, Abcam, 1:750) was 
performed  on  chosen  sections  (overnight  incuba-
tion, 4ºC). 
All primary antibody incubations were preceded 
by specimen incubation in 3% hydrogen peroxide 
and protein block, followed by sequential incuba-
tions with a biotinylated antibody and peroxidase-
labeled  streptavidin.  Staining  was  completed  after 
incubation in a DAB+chromogen solution (Mouse 
and  Rabbit  Specific  HRP/DAB  detection  IHC  kit, 
ab64264,  Abcam).  The  nuclei  were  counterstained 
with Mayer’s hematoxylin.
All  immunostained  sections  were  analyzed  on 
a Leica DMRB Photo Microscope and photographs 
were taken using a JVC TK 1280E Video Camera 
(Leica) and the QWin program (Leica).
Electron microscopy
After short fixation in 10% (v/v) neutral buffered 
formalin and washing by three changes of phos-
phate buffer (one change daily), tissue samples of 
the pancreas from each group were cut into small 
blocks  (approx.  1  mm3)  and  immersed  in  2.5% 
glutaraldehyde  in  0.1  M  phosphate  buffer  (pH-
7.4) for 60 min. All specimens were post-fixed for 
1 h in 1% osmium tetroxide in the same buffer, 
dehydrated in a series of increasing ethanol con-
centrations and propylene-oxide, and embedded 
in Araldite. Ultrathin sections were obtained us-
ing a Leica EM UC6 ultramicrotome, contrasted 
with uranyl acetate and lead citrate, and examined 
under a Philips CM 12 electron microscope. Elec-
tron micrographs of β-cells enabled us to precisely 
determine the number of granules per unit area, 
using  Image  J  1.45  software.  These  images  also 
served for the assessment of mature vs. immature 
granules ratio.
Stereological analysis
Stereological analysis of islets and their insulin-pro-
ducing cells were performed by a ‘point counting’ 
technique, using Weibel’s multipurpose test grid M 
42 (Weibel et al., 1966). Conventional morphometry 
and standard stereological equations were used to 
calculate  the  following  parameters:  islet  diameter, 
volume and numerical density of islets, number of 
islets per unit area, total number of islets, and islet 
mass; volume density of β-cells, β-cell mass, profile 
area of a single endocrine cell and number of β-cells 
per islet. 
With a graticule of a calibrated linear scale, the 
major (a) and minor (b), and axes of the islets at a 
right angle to (a), were measured and the mean islet 
diameter was calculated. The relative volume (volume 
density or Vv) of the islets was calculated by dividing 
the number of points over the islets by the number of 
points over the total tissue section. The number of is-
lets per unit area (numerical area density or NA) was 
determined by the formula NA= N/AT, where N is the 
number of sectioned profiles of islets and AT the area 
of the section. The equation AT = Pt x √3/2 x d2 was 
used to determine the area of the section, where Pt  is 
the number of hits over the section and d is the test 
line. The numerical density of islets (Nv) was deter-
mined using the method of DeHoff and Rhines as 
described by Aherne and Dunnill (1982a): Nv=k/β x 
√NA
3/Vv, where k/β=1.485, the constant value for a 
sphere. The absolute (total) number of islets was ob-
tained by multiplying the numerical density of the is-
lets by the pancreatic volume, which was determined 
according to Aherne and Dunnill (1982b) from the 
formula V (ml) = 0.95 x W (g), where W is pancre-
atic weight. Islet mass was calculated by multiplying 
the islet volume density by pancreas weight.
The relative volume (volume density, Vv) of β-cells 
in the islets of Langerhans was calculated by dividing 
the number of points over immunohistochemically 
stained β-cells by the number of points over the is-
lets. The mass of β-cells was determined by multi-
plying the volume density of β-cells by the pancreas 
weight. The profile area of the β-cell was also estimat-946 MIRELA UKROPINA ET AL.
ed on the immunohistochemically stained sections 
of pancreas. This was obtained by dividing the total 
profile area of the β-cells by the total number of cells. 
The equation AT = Pt x √3/2 x d2 was used to deter-
mine the area of endocrine cells in individual islets 
of Langerhans, where AT is the total β-cell area, Pt is 
number of hits on β-cells and d is the test line. The 
number of β-cells per islet was obtained by dividing 
the number of β-cells over the number of islets.
Statistics
Values are presented as means ± standard error of 
mean (SEM). Student’s t- test was used for statisti-
cal analysis; p values < 0.05 were regarded as being 
statistically significant.
RESULTS
Applied MMI treatment induced systemic hypothy-
roidism, which was confirmed by the decreased lev-
els of both serum T3 and T4 (Table 1). This resulted 
in growth retardation, manifested by a significantly 
decreased body weight gain. The absolute and rela-
tive pancreatic masses were also decreased, although 
the reduction in relative mass was not statistically 
significant. The serum insulin level was decreased, 
but without statistical significance.
During the experiment, lower food and fluid in-
take were recorded in the MMI-treated animals (Ta-
ble 1).
Histology and immunohistochemistry
Under  light  microscopy,  differences  between  the 
groups in the general histological appearance of the 
Langerhans islets were not observed. Immunohisto-
chemically stained β-cells were located in the central 
portion of the Langerhans islets. However, the im-
munopositive reaction appeared to be more intense 
in the hypothyroid animals (Fig. 1).
Immunolabeling of PDX1-positive cells showed 
a clear difference in the expression of this nuclear 
protein between the groups (Figs. 2a and b). In the 
control  group,  numerous  immunopositive  nuclei 
were distributed predominantly in the central part of 
the islets, while in the MMI-treated animals a weak 
reaction was rarely observed. 
Cell  proliferation  was  assessed  on  Ki67  im-
munohistochemically labeled tissue. In the control 
rats, immunopositive cells were scattered through-
out the central portion of the islet (Fig. 3a). In the 
MMI-treated animals, however, rare Ki67 positivity 
was observed at the islet periphery, while it was ab-
Table 1. Effects of MMI treatment on the rat body and pancreatic masses, daily food and fluid intake, and some biochemical parameters 
in serum. Values are means ± SEM of eight animals.
Control Methimazole p value
Initial body mass (g) 217.5 ± 9.6 218.0 ± 7.4 n.s.
Final body mass (g) 352.7 ± 9.5 293 ± 5.9 < 0.001
Body mass gain (g) 135.2 ± 1.8 75.0 ± 6.8 < 0.001
Average daily food intake (g) 28.36 ± 0.62 22.63 ± 0.56 < 0.001
Average daily fluid intake (ml) 42.45  ± 1.20 33.58 ± 1.58 < 0.05
Pancreatic mass (g) 1.11 ± 0.05 0.82 ± 0.02 < 0.001
Relative pancreatic mass (g/100g BM) 0.314  ± 0.015 0.279 ± 0.006 n.s.
Insulin (mIU/l) 90.72  ± 11.42 68.30  ±  5.17   n.s.
T3 (nmol/l) 1.23 ± 0.10 0.97 ± 0.06 < 0.05
T4 (nmol/l) 88.50 ± 3.07 3.42 ± 0.56   < 0.001β-CELLS IN HyPOTHyROIDISM 947
Fig. 1. Insulin containing β-cells occupy the central portion of the islets, and display moderately strong staining in control rats (a) and 
intense reaction in methimazole treated rats (b). (bar=50µm)
Fig. 2. Strong PDX1 immunopositivity is evident in the central portion of the islet of Langerhans in control pancreas (a). In hypothyroid 
pancreas (b) weaker reaction is present in a few centrally placed islet cells. (bar=50µm)
Fig. 3. In control pancreas Ki67-positive nuclei were scattered through the central portion of the islet (a). Ki67 positive β-cells are ab-
sent in islet of methimazole treated rats (b). Immunopositivity is present in scarce peripherally placed cells, corresponding to α-cells. 
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sent among the cells that positionally correspond to 
β-cells (Fig. 3b).
The propidium iodide-stained pancreas revealed 
sporadic homogenous, bright red apoptotic nuclei 
in  both  the  control  and  hypothyroid  group  (not 
shown).
Stereological results
The results of stereological investigation of the pan-
creatic islets are presented in Table 2. Since the abso-
lute pancreas volume was reduced after MMI treat-
ment while the islet number, mass and mean islet 
diameter were unchanged, the number of pancreatic 
islets per unit area and per unit volume consequently 
increased.  However,  the  decrease  in  pancreas  size 
was not sufficient to significantly affect the islets’ vol-
ume density.
Quantitative analysis of β-cells (Table 3) showed 
that the profile area of a single β-cell was significantly 
decreased, while other parameters (β-cells’ volume 
density, mass and number per islet) remained un-
changed. 
The β-cell granules are membrane-bound spher-
ical vesicles containing a dense core, surrounded by 
an electron-lucent halo. Electron microscopic study 
of β-cell granules revealed that in comparison to the 
control, the granules in the MMI-treated group were 
closely packed and more often possessed a circular 
Table 2. Results of stereological investigation of pancreatic islets in control and methimazole treated rats. Values are means ± SEM of 
eight animals.
Control Methimazole p value
Absolute volume of pancreas (ml) 1.05  ±  0.049 0.78 ± 0.021 <0.001
Vv of islets (mm0) 0.012 ± 0.0027 0.016 ± 0.0022 n.s.
NA (number of islets per mm2) 0.73 ± 0.12 1.19 ± 0.13 <0.05
Nv (number of islets per cm3) 8919 ± 1686 16214 ± 2069 <0.05
Absolute number of islets 9188 ± 1655 12489 ± 1423 n.s.
Mean islet diameter (μm) 135 ± 15.9 125 ± 8.1 n.s.
Islet mass (mg) 12.9 ± 2.6 13.4 ± 1.9  n.s.
Fig. 4. Granules with square dense core are evident throughout the control β-cell (a). Typical β-cell from methimazole treated rats con-
tains more numerous tightly packed granules with round dense core (b). (Orig. magn. x 8800)β-CELLS IN HyPOTHyROIDISM 949
instead of angular dense core, which is considered as 
sign of immaturity (Dodson and Steiner, 1998) (Figs. 
4a and b). Indeed, a detailed stereological analysis 
of the electron micrographs showed a significant in-
crease in the number of granules per unit area in the 
MMI-treated  animals.  In  addition,  the  percentage 
ratio in this group was in favor of immature granules 
(Table 3). 
In the MMI-treated animals, ultrastructural ob-
servation revealed within the islets the existence of 
individual α-like cells that, like the cell-specific gran-
ules, also contained those resembling β-cell granules 
(Fig. 5).
DISCUSSION
To investigate the effects of systemic hypothyroidism 
on the immunohistochemical, stereomorphometric 
and some ultrastructural characteristics of pancre-
atic β-cells, we used an experimental model in which 
hypothyroidism was induced in rats by the antithy-
roid drug methimazole provided in drinking water, 
at a concentration of 0.02%, during 3 weeks. This 
treatment is conventionally used for establishing a 
hypothyroid state (Cooper et al., 1984; Petrovic et al., 
2001), and its efficacy in this experiment was dem-
onstrated by a significant decrease in both thyroid 
hormone serum levels.
The most remarkable effect of systemic hypothy-
roidism at the level of the whole organism was the 
significant lowering of body mass gain in the MMI-
treated rats during the experiment. It is well known 
that a lack of thyroid hormones negatively affects 
all metabolic processes in the body, exerting an es-
pecially strong influence on protein synthesis (Tata 
et al., 1963; Tapley, 1964). At the same time, due to 
reduced energy expenditure, requirements for food 
and fluid consumption were also decreased, result-
ing in the reduced gain in body mass gain noted in 
this study. 
Our results show that pancreatic mass was sig-
nificantly lower in hypothyroid animals, but with-
out changes in size, i. e. mass, diameter and number 
of its endocrine component. This indicates that the 
decrease in pancreatic mass is related entirely to the 
Table 3. Results of stereological investigation of β-cells in control and methimazole treated rats. Values are means ± SEM of eight ani-
mals. 
Control Methimazole p value
Vv of  β-cells (mm0) 0.79 ± 0.034 0.73 ± 0.026 n.s.
β-cells mass (mg) 13.4 ± 3.3 12.4 ± 2.1 n.s.
Number of β-cells per islet 25.6 ± 4.08 32.5 ± 4.50 n.s.
Profile area of single β-cell (μm2) 299.2 ± 24.7 202.8 ± 8.1 <0.01
Number of granules per 100 μm2 194 ± 14.90 398 ± 63.17 < 0.01
Granules with circular core (%) 77  ± 1.37 96 ± 1.07 < 0.001
Granules with angular core (%) 23 ± 1.37 4  ± 1.07  < 0.001
Fig. 5. In methimazole treated animals, at the islet periphery 
where majority of cells are of α type, peculiar cell is visible (top 
left): cytoplasm at its upper end is filled with typical dark α-cell 
granules, but below the nucleus granules possess wider halo, 
which is the hallmark of β-cell granules. (Orig. magn. x 2650)950 MIRELA UKROPINA ET AL.
reduction of its exocrine component. The unchanged 
relative pancreatic mass indicates that the reduction 
in the mass of the pancreas took place in parallel 
with body mass reduction and could be caused by a 
general growth cessation. 
The  results  of  our  stereological  analysis  re-
vealed  that  the  relevant  quantitative  parameters 
for Langerhans islets, such as the volume density 
(Vv), total number, mean diameter and mass, re-
mained unaltered in the pancreas of hypothyroid 
rats. At the same time, neither remarkable changes 
in cell death nor proliferation were demonstrated 
in slides stained with propidium iodide and im-
munostained for the proliferative marker Ki67, re-
spectively. Taken together, these findings suggest 
that the applied treatment did not seriously affect 
the balanced turnover of β-cell population, leav-
ing it relatively stable, as is the case in a normal 
adult pancreas (Ackermann and Gannon, 2007). 
Namely,  during  adulthood  β-cells  are  a  slowly 
renewing population, possessing steady and low 
rates  of  proliferation  and  apoptosis.  Even  when 
β-cell  mass  expands  in  line  with  an  age-related 
increase in body weight, it is the result of an in-
crease in individual cell size, rather than increas-
ing  proliferation  (Montanya  et  al.,  2000).  Given 
that the absolute pancreas mass and volume were 
significantly  reduced,  the  increase  in  numerical 
area density (NA) and numerical density (NV) of 
islets was to be expected. Despite this, there was 
no significant change in the volume density (VV) 
of the islets, although it slightly increased. Since 
the pancreas can be considered to be a relatively 
quiescent organ in response to altered metabolic 
conditions (Bonner-Weir et al., 1993), this finding 
could be explained by an insufficient duration of 
the treatment.  
Despite the overall stability of the β-cell popula-
tion, stereological analysis unequivocally suggests a 
cessation in both the synthesis and release of insu-
lin. The ultrastructural appearance of β-cell granules 
suggests an interruption in insulin secretion, since 
granules were more numerous in the cytoplasm of 
β-cells from the MMI-treated rats. Moreover, imma-
ture granules with a circular dense core were detect-
ed in a significantly greater percentage in this group. 
Insulin gene expression is under the direct positive 
control of the PDX1 transcription factor, which is 
in turn positively controlled by T3 (Campbell and 
Macfarlane, 2002; Andrali et al., 2008). The dramatic 
drop in PDX1-positive cells, which we observed in 
the islets of MMI-treated rats, is in accordance with 
this regulatory mode.
Electron  microscopical  observations  revealed 
the existence of several cells that, according to most 
ultrastructural features, corresponded to glucagon-
producing  α-cells.  However,  in  the  cytoplasm  of 
these cells, typical insulin-like granules were visible, 
clustered together in a precisely defined area (Fig. 
5). It is known from a previous report by Chung and 
Levine  (2010)  that  α-cells  possess  the  capacity  to 
co-express insulin and glucagon. In our opinion, in 
MMI-treated rats these glucagon/insulin co-express-
ing cells provide certain compensation for the defi-
cient insulin-producing/secreting role of β-cells. The 
absence of a statistically significant decrease in the 
insulin concentration in the sera of hypothyroid rats 
could be explained, at least in part, by the secretory 
activity of these cells.
In conclusion, systemic hypothyroidism induced 
by MMI affects the endocrine pancreas, primarily by 
altering the ultrastructure and thus the function of 
its β-cell population. Newly emerged glucagon/insu-
lin co-expressing α-like cells provide a nearly normal 
level of insulin in the circulation, thus compensating 
for the suppressed ability of β-cells to produce and/
or release insulin.
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